Waters Corporation (WAT)
Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern
Waters Corp reported better-than-expected Q4'24 and FY'24 results, driven by strong performance in academia, government, and pharma segments, despite FX headwinds impacting gross margins. The company anticipates continued growth in 2025, with projected revenue growth between 4.5% and 7%, supported by emerging markets like India and high-growth areas like GLP-1 and PFAS testing. Risks include elevated valuations and limited opportunities for cash deployment, making buybacks less attractive; current valuation appears challenging compared to historical averages and peers.
WAT Earnings & Sales Surpass Estimates in Q4, Shares Rise
WAT's fourth-quarter 2024 results reflect strong pharma growth and robust gains across all regions. However, forex headwinds hurt.
Waters Corporation (WAT) Q4 2024 Earnings Call Transcript
Waters Corporation (NYSE:WAT ) Q4 2024 Earnings Conference Call February 12, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President & Chief Executive Officer Amol Chaubal - Senior Vice President & Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - Leerink Eve Burstein - Bernstein Brandon Couillard - Wells Fargo Dan Arias - Stifel Dan Brennan - TD Cowen Catherine Schulte - Baird Operator Good morning. Welcome to the Waters Corporation Fourth Quarter 2024 Financial Results Conference Call.
Waters (WAT) Q4 Earnings and Revenues Top Estimates
Waters (WAT) came out with quarterly earnings of $4.10 per share, beating the Zacks Consensus Estimate of $4.02 per share. This compares to earnings of $3.62 per share a year ago.
Weighing In On Waters Corporation: Facing A Valuation Headwind
Today, we take a more in-depth look at Waters Corporation, which provides analytical workflow solutions, primarily to the Pharma and Industrial industries. WAT stock has surged 35% since July lows, but analysts are growing increasingly cautious due to valuation concerns, with mixed ratings and tepid price targets. From a historical perspective, the equity now trades at the very top of its historical P/S and P/E ratios.
Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?
TECH enters a co-marketing and co-promotion agreement with Waters Corporation to expand the reach of advanced biotherapeutic characterization and development processes.
Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View
WAT's third-quarter 2024 results show growth in the pharma and industrial sectors. A dip in China sales creates headwinds.
Waters Stock Leads S&P 500 Gains Friday as Earnings Top Estimates
Shares of Waters Corp. (WAT) surged nearly 20% on Friday, delivering the top daily performance in the S&P 500 after the company reported third-quarter sales and earnings that topped analysts' projections.
S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve
Following a pair of negative trading sessions, major U.S. equities indexes closed out the week on a strong note, pushing higher on Friday as investors cheered upbeat earnings results from e-commerce and cloud computing behemoth Amazon (AMZN).
Waters Corporation (WAT) Q3 2024 Earnings Call Transcript
Waters Corporation (NYSE:WAT ) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Caspar Tudor – Head of Investor Relations Udit Batra – President and Chief Executive Officer Amol Chaubal – Senior Vice President and Chief Financial Officer Conference Call Participants Tycho Peterson – Jefferies Brandon Couillard – Wells Fargo Puneet Souda – Leerink Partners Vijay Kumar – Evercore ISI Dan Brennan – TD Cowen Matt Sykes – Goldman Sachs Operator Good morning, and welcome to the Waters Corporation Third Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode until the question-and-answer session begins.
Waters (WAT) Beats Q3 Earnings and Revenue Estimates
Waters (WAT) came out with quarterly earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.68 per share. This compares to earnings of $2.84 per share a year ago.
Waters Corp raises annual profit forecast on higher demand for lab equipment
Waters Corp raised its annual profit forecast after beating Wall Street estimates for third-quarter profit and revenue on Friday, on improved demand for its products and services used in drug development and research.
